← Back to Patent Explorer
US6077988A Expired / Lapsed US ⏱️ 0.0 years remaining

Synthetic bone matrix

Assignee: MARIEL THERAPEUTICS Inc
•
Filing: 1995-05-18
•
Granted: 2000-06-20
•
Expires: 2015-05-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed is an osteogenic device capable of inducing the formation of endochondral bone in a shape conforming substantially to the shape of the device when implanted in a mammalian host. The device includes an osteogenic protein dispersed within a porous matrix comprising a polymer of collagen and glycosaminoglycan cross-linked to an M c value of about 800 to about 60,000. Also disclosed are a method of inducing mammalian bone growth, and a method of inducing conductive bone growth from viable mammalian bone.

Inventors

  • 👤 Thangavel Kuberasampath
  • 👤 Lawrence Berlowitz Tarrant

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:28
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/14; A61L27/22; A61L27/227; A61L27/40; A61L27/44; A61L27/48; A61F; A61F2/00; A61F2/02; A61F2/28; A61L2430/00; A61L2430/02

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 67 words
An osteogenic device for inducing formation of endochondral bone in a mammal in a shape conforming substantially to the shape of said device, said device comprising an osteogenic protein dispersed within a biocompatible, synthetic, porous matrix comprising a polymer of collagen and glycosaminoglycan crosslinked ex vivo to an M c value of about 800 to about 60,000 and comprising greater than 1% by weight, of said glycosaminoglycan.
Claim 2
Dependent Claim 67 words
An osteogenic device for inducing formation of endochondral bone in a mammal in a shape conforming substantially to the shape of said device, said device comprising an osteogenic protein dispersed within a biocompatible, synthetic, porous matrix comprising a polymer of collagen and glycosaminoglycan crosslinked ex vivo to an M c value of about 800 to about 60,000 and comprising greater than 1% by weight, of said glycosaminoglycan.
Claim 3
Dependent Claim 17 words
The device of claim 1 wherein said glycosaminoglycan comprises at least 5% by weight of said polymer.
Claim 4
Dependent Claim 20 words
The device of claim 2 wherein said glycosaminoglycan comprises from about 6% to about 15% by weight of said polymer.
Claim 5
Dependent Claim 31 words
The device of claim 1 wherein said glycosaminoglycan is selected from the group consisting of chondroitin 4-sulfate, chondroitin 6-sulfate, hyaluronic acid, dermatan sulfate, keratan sulfate, heparin, heparan sulfate, and combinations thereof.
Claim 6
Dependent Claim 12 words
The device of claim 1 wherein said glycosaminoglycan comprises a sulfate group.
Claim 7
Dependent Claim 11 words
The device of claim 5 wherein said glycosaminoglycan comprises chondroitin 6-sulfate.
Claim 8
Dependent Claim 20 words
The device of claim 1 wherein said polymer is cross-linked to an M c value of between 5,000 and 10,000.
Claim 9
Dependent Claim 88 words
The device of claim 1 wherein said osteogenic protein comprises a pair of subunits constituting a dimer under oxidizing conditions, one of said subnits having an amino acid sequence comprising the amino acid sequence of OP1 (SEQ ID NO:1): 1 10 20 30 40 - STGSKQRSQNRSKTPKNQEALRMANVAENSSSDQRQACKKHELYV 50 60 70 80 90 - SFRDLGWQDWIIAPEGYARYYCEGECAFPLNSYMNATNHAIVQTL 100 110 120 130 - VHFINPETVPKPCCAPTQLNAISVLYFDDSSNVILKKYRNMVVRACGCH such that said subunit, when in combination with the second of said subunits, induces endochondral bone formation in a mammal when disposed within said matrix implanted in said mammal.
Claim 10
Dependent Claim 24 words
The device of claim 1 wherein said polymer is selected from the group consisting of Type I collagen, Type II collagen, and mixtures thereof.

References Cited (Backward Citations)

US4418691A Cited
US5007934A Cited
US5258043A Cited
US4947840A Cited
US5266683A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2003-06-20 2003-12-20 2004-06-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2007-06-20 2007-12-20 2008-06-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2011-06-20 2011-12-20 2012-06-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag